Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BIOMEA FUSION, INC.

(BMEA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Certain Stock Options of Biomea Fusion, Inc. are subject to a Lock-Up Agreement Ending on 13-OCT-2021.

10/13/2021 EDT

Certain Stock Options of Biomea Fusion, Inc. are subject to a Lock-Up Agreement Ending on 13-OCT-2021. These Stock Options will be under lockup for 181 days starting from 15-APR-2021 to 13-OCT-2021. Details: The directors and executive officers, and substantially all of our securityholders have entered into lock-up agreements with the underwriters prior to the commencement of this offering pursuant to which each lock-up party, with limited exceptions, for a period of 180 days after the date of this prospectus, may not and may not cause any of their direct or indirect affiliates to, without the prior written consent of J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co.


© S&P Capital IQ 2021
All news about BIOMEA FUSION, INC.
10/1319,767,867 Common Stock of Biomea Fusion, Inc. are subject to a Lock-Up Agreement Endin..
CI
10/13Certain Stock Options of Biomea Fusion, Inc. are subject to a Lock-Up Agreement Ending..
CI
09/21INSIDER BUY : Biomea Fusion
MT
09/20BIOMEA FUSION, INC.(NASDAQGS : BMEA) added to S&P Global BMI Index
CI
09/17BIOMEA FUSION : Announces FDA Clearance of Investigational New Drug Application for Irreve..
PU
09/16BIOMEA FUSION : Gets FDA Clearance to Start Early-Stage Trial of BMF-219 in Acute Leukemia
MT
09/16BIOMEA FUSION : Announces FDA Clearance of Investigational New Drug Application for Irreve..
AQ
09/16Biomea Fusion, Inc. Announces FDA Clearance of Investigational New Drug Application for..
CI
08/11BIOMEA FUSION : Reports Second Quarter 2021 Financial Results and Business Highlights (For..
PU
08/11BIOMEA FUSION : Management's Discussion and Analysis of Financial Condition and Results of..
AQ
More news
Analyst Recommendations on BIOMEA FUSION, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -39,7 M - -
Net Debt 2021 - - -
P/E ratio 2021 -6,90x
Yield 2021 -
Capitalization 337 M 337 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 20
Free-Float 66,5%
Chart BIOMEA FUSION, INC.
Duration : Period :
Biomea Fusion, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOMEA FUSION, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 11,63 $
Average target price 26,00 $
Spread / Average Target 124%
EPS Revisions
Managers and Directors
Thomas Butler Chairman & Chief Executive Officer
Ramses Erdtmann President, Chief Operating Officer & Director
Franco Valle Chief Financial & Accounting Officer
Heow Tan Chief Technology & Quality Officer
Anthony Souza Head-Information Technology
Sector and Competitors
1st jan.Capi. (M$)
BIOMEA FUSION, INC.0.00%337
MODERNA, INC.210.34%130 866
LONZA GROUP AG26.90%58 060
IQVIA HOLDINGS INC.38.89%47 683
SEAGEN INC.-1.38%31 426
CELLTRION, INC.-38.72%25 414